205 related articles for article (PubMed ID: 32217557)
1. Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial.
Zolnourian AH; Franklin S; Galea I; Bulters DO
BMJ Open; 2020 Mar; 10(3):e028514. PubMed ID: 32217557
[TBL] [Abstract][Full Text] [Related]
2. Seizure prophylaxis following aneurysmal subarachnoid haemorrhage (SPSAH): study protocol for a multicentre randomised placebo-controlled trial of short-term sodium valproate prophylaxis in patients with acute subarachnoid haemorrhage.
Chen Y; Fang M; Wu P; Xie Z; Wu H; Wu Q; Xu S; Li Y; Sun B; Pang B; Zheng N; Zhang J; Hu X; You C
BMJ Open; 2022 May; 12(5):e057917. PubMed ID: 35508338
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
[TBL] [Abstract][Full Text] [Related]
4. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.
Dorhout Mees SM; Algra A; Vandertop WP; van Kooten F; Kuijsten HA; Boiten J; van Oostenbrugge RJ; Al-Shahi Salman R; Lavados PM; Rinkel GJ; van den Bergh WM;
Lancet; 2012 Jul; 380(9836):44-9. PubMed ID: 22633825
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
BMJ; 1989 Mar; 298(6674):636-42. PubMed ID: 2496789
[TBL] [Abstract][Full Text] [Related]
6. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial.
Springborg JB; Møller C; Gideon P; Jørgensen OS; Juhler M; Olsen NV
Acta Neurochir (Wien); 2007 Nov; 149(11):1089-101; discussion 1101. PubMed ID: 17876497
[TBL] [Abstract][Full Text] [Related]
8. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
Gathier CS; van den Bergh WM; Slooter AJ;
Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
[TBL] [Abstract][Full Text] [Related]
9. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
[TBL] [Abstract][Full Text] [Related]
10. Excessive release of endogenous neuropeptide Y into cerebrospinal fluid after treatment of spontaneous subarachnoid haemorrhage and its possible impact on self-reported neuropsychological performance - results of a prospective clinical pilot study on good-grade patients.
Bründl E; Proescholdt M; Schödel P; Bele S; Höhne J; Zeman F; Stoerr EM; Brawanski A; Schebesch KM
Neurol Res; 2018 Dec; 40(12):1001-1013. PubMed ID: 30213237
[TBL] [Abstract][Full Text] [Related]
11. Prolong: a double-blind randomised placebo-controlled trial of broccoli sprout extract in women with early onset preeclampsia. A clinical trial protocol.
Langston-Cox AG; Marshall SA; Palmer KR; Wallace EM
BMJ Open; 2019 Oct; 9(10):e027493. PubMed ID: 31628121
[TBL] [Abstract][Full Text] [Related]
12. CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial.
Koopman I; Rinkel GJE; Vergouwen MDI;
Trials; 2020 Nov; 21(1):969. PubMed ID: 33239044
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.
Woo PYM; Ho JWK; Ko NMW; Li RPT; Jian L; Chu ACH; Kwan MCL; Chan Y; Wong AKS; Wong HT; Chan KY; Kwok JCK
BMC Neurol; 2020 Nov; 20(1):401. PubMed ID: 33143640
[TBL] [Abstract][Full Text] [Related]
15. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
Siironen J; Juvela S; Varis J; Porras M; Poussa K; Ilveskero S; Hernesniemi J; Lassila R
J Neurosurg; 2003 Dec; 99(6):953-9. PubMed ID: 14705720
[TBL] [Abstract][Full Text] [Related]
16. Aneurysmal subarachnoid haemorrhage-cerebral vasospasm and prophylactic ibuprofen: a randomised controlled pilot trial protocol.
Dayyani M; Mousavi Mohammadi E; Ashoorion V; Sadeghirad B; Javedani Yekta M; Grotta JC; Gonzalez NR; Zabihyan S
BMJ Open; 2022 Apr; 12(4):e058895. PubMed ID: 35414560
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.
Kirkpatrick PJ; Turner CL; Smith C; Hutchinson PJ; Murray GD;
Lancet Neurol; 2014 Jul; 13(7):666-75. PubMed ID: 24837690
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of cilostazol-nimodipine combined therapy on delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a prospective, randomised, double-blinded, placebo-controlled trial protocol.
Dawley T; Claus CF; Tong D; Rajamand S; Sigler D; Bahoura M; Garmo L; Soo TM; Kelkar P; Richards B
BMJ Open; 2020 Oct; 10(10):e036217. PubMed ID: 33020083
[TBL] [Abstract][Full Text] [Related]
19. The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial.
Singh N; Hopkins SJ; Hulme S; Galea JP; Hoadley M; Vail A; Hutchinson PJ; Grainger S; Rothwell NJ; King AT; Tyrrell PJ
J Neuroinflammation; 2014 Jan; 11():1. PubMed ID: 24383930
[TBL] [Abstract][Full Text] [Related]
20. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.
Veyna RS; Seyfried D; Burke DG; Zimmerman C; Mlynarek M; Nichols V; Marrocco A; Thomas AJ; Mitsias PD; Malik GM
J Neurosurg; 2002 Mar; 96(3):510-4. PubMed ID: 11883835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
